Surgery Partners, Inc.

NASDAQ:SGRY

Medical - Care Facilities

Healthcare
$26.96 +0.39%

+$0.06 today

Market cap
$3.53B
Beta
1.95
P/E (TTM)
-24.1
EPS (TTM)
-$0.59
52W Low $11.41High $24.10

Volume 3.24M

Average 1.36M

SGRY Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Surgery Partners, Inc.NASDAQ: SGRY

Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026

Capital expenditures growth accelerates

Q3 FY2026 capital expenditures of $24.5M (cash outflow) rose 23.7% year over year, ahead of the -14.9% change in trailing-twelve-month capital expenditures. Sequentially, it rose 12.4% from the prior quarter. Over 3 fiscal years it compounded at -0.8% a year.

Context

  • Capital expenditures amounted to 2.4% of revenue in FY2025, down 0.5 pp from a year earlier.
  • Capital expenditures grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +23.7% holds above the trailing-twelve-month pace of -14.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$24.5M+12.4% QoQ
Last fiscal yearDec 2025
-$78.7M-12.9% YoY
LTMSep 2026
-$75.1M-14.9% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+23.7%——
1 year-12.9%——
3-year CAGR-0.8%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(78.7M) USD
Year-over-year change
+12.9%

Capital Expenditures vs competitors

How SGRY compares with its peers on the latest reported figures

  • SGRY's LTM Sep 2026 capital expenditures of $75.1M is the 6th largest of the 7 companies compared; the peer median is $649.79M.
  • Its year-over-year change of -14.9% is the lowest of 7, against a peer median of +10.2%.
  • Capital expenditures amounts to 2.2% of revenue for SGRY, versus a peer median of 4.0%.
SGRY Competitors Peer median
Capital Expenditures for SGRY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HCAHCA Healthcare, Inc.LTM Jun 2026$5.13B +10.4%+4.0%6.6%
THCTenet Healthcare CorporationLTM Jun 2026$992M +10.0%+9.8%4.5%
UHSUniversal Health Services, Inc.LTM Jun 2026$973.58M -2.5%+11.4%5.4%
CYHCommunity Health Systems, Inc.LTM Mar 2026$326M -7.4%-6.9%1.5%
ARDTArdent Health Partners, LLCLTM Mar 2026$217.08M +16.4%+11.9%3.4%
SGRYSurgery Partners, Inc.LTM Sep 2026$75.1M -14.9%-0.8%2.2%
NUTXNutex Health, Inc.LTM Mar 2026$3.66M +124.1%-44.3%0.4%
Peer median (excluding SGRY) $649.79M+10.2%+6.9%4.0%

Competitors are the stored peer set for SGRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income70.7M87M135.3M12.5M98.9M
Depreciation & Amortization98.8M114.8M118.1M152.6M176M
Deferred Income Tax8.9M21.9M(1.7M)131.5M16.7M
Stock-Based Compensation17.4M18.4M17.7M33.3M14.8M
Change in Working Capital(149.1M)(102.3M)(62.3M)(118.9M)(110.4M)
Accounts Receivables(32.1M)(35.3M)(47.2M)(72.1M)(53.8M)
Inventory00000
Accounts Payables00000
Other Working Capital(117M)(67M)(15.1M)(46.8M)(56.6M)
Other Non-Cash Items40.4M19M86.7M89.1M78.3M
Operating Cash Flow87.1M158.8M293.8M300.1M274.3M
Capital Expenditures(57.6M)(80.6M)(88.8M)(90.4M)(78.7M)
Acquisitions (Net)(280.4M)(228.7M)(128.9M)(378.8M)(162.1M)
Purchases of Investments000(1.7M)(13.3M)
Sales of Investments0004.6M0
Other Investing Activities6.3M1.4M(7.9M)(22.2M)7.5M
Investing Cash Flow(331.7M)(307.9M)(225.6M)(488.5M)(246.6M)
Debt Repayment(43.8M)(644.2M)19.5M450.4M158.7M
Common Stock Issued581.8M882.9M000
Common Stock Repurchased00000
Dividends Paid(5.1M)0000
Other Financing Activities(216.6M)(196.6M)(174.7M)(188.4M)(216M)
Financing Cash Flow316.3M42.1M(155.2M)262M(57.3M)
Effect of Forex Changes00000
Net Change in Cash71.7M(107M)(87M)73.6M(29.6M)
Free Cash Flow29.5M78.2M205M209.7M195.6M

Surgery Partners, Inc.

NASDAQ:SGRY

Intrinsic Alpha fair value

Locked

Current Price

$26.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.